مقایسۀ تأثیر دو شدت فعالیت حاد هوازی بر غلظت آپلین پلاسما، گلوکز خون و شاخص مقاومت به انسولین مردان مبتلابه دیابت نوع دو

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89(6): 2548-56.
2. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S,et al. Molecular properties of apelin: Tissue distribution and receptor binding. Biochim Biophys Acta. 2001; 1538(2-3): 162-71.
3. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, et al. The novel peptide apelin lowers blood pressure via a nitric-dependent mechanism. Regul Pept. 2001; 99(2-3): 87-92.
4. Castan-LaurellI, Boucher J, Dray C, Daviaud D,Guigne C, Valet P. Apelin, a novel adipokine overproduced in obesity: Friend or foe? Mol Cell Endocrinol. 2005; 245(1):    7–9.
5. Wei L, Hou X, Tatemoto K. Regulation of apelin m RNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept. 2005; 132(1-3): 27-32.
6. محبی حمید، رحمانی­نیا فرهاد، هدایتی امامی محمدحسن، سعیدی ضیابری تهمینه. تأثیر 8 هفته تمرین هوازی با شدت متوسط بر سطوح آپلین پلاسما و مقاومت به انسولین در زنان مبتلا به دیابت نوع 2. فیزیولوژی ورزشی. 1392؛ (20) 5: 28 ـ115.
7. Bełtowski J. Apelin and visfatin: Unique beneficial adipokines upregulated in obesity? Med Sci Monit. 2006; 12(6): 112-9.
8. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, et al. Apelin, a newly identified adipokine upregulated by insulin and obesity. Endnocrinology. 2005; 146(4): 1764-71.
9. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun.1998, 251(2): 471-6.

10. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y. Apelin (65-77) activates p70 S6 Kinase and is mitogenic for umbilical endothelial cells. FASEBJ. 2004; 18(15):     1909-11.

11. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006; 114(10): 544-8.

12. Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S. Low plasma apelin levels in newly diagnosed type 2diabetes mellitus. Exp Clin Endocrinol Diabetes. 2008; 116(05): 289-92.

13. Zhang Y, Shen C, Li X, Ren G, Fan X, Ren F, et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care. 2009; 32(12): 150-8.

14. Shiming XU, Philip S, Patrick Y. Apelin and insulin resistance: Another arrow for the quiver? J Diabetes. 2011;3(3):225-31

15. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garsia-almida J, Garsia-arnes J, Francisco J, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009; 19(11): 1574-80.

16. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M,et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.Cell Metab. 2008; 8(5):  437-45.

17. Sorhede Winzell M, Magnusson C, Ahren B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept. 2005; 131(1-3):12-7.

18. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003; 108(12): 1432-9.

19. Ringström C, Nitert MD, Bennet H, Fex M, Valet P, Rehfeld JF, et al. Apelin is a novel islet peptide.Regul Pept. 2010; 162(1-3): 44-51.

20. Yue P, Hong J­, Aillaud M, Alicia C, et al. Apelin are necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010; 298(1): 59–67.

21. Attane C, Daviaud D, Dray C, Dusaulcy R, Masseboeuf M, Prevot D, et al. Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. JMolEndocrinol. 2010; 46(1): 21–8.

22. Kadoglou N, Ioannis S, Vrabas I, Kapelouzou A, Lampropoulos S, Sailer N, et al. The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit. 2012; 18(5): 290-5.

23. Sigal RJ, Kenny GP, Wasserman DH. Physical activity/exercise and type 2 diabetes: A consensus statement from the American Diabetes Association. Diabetes Care. 2006; 29(6): 1433-8.

24. Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013; 17(2): 162-84.

25. Blair SN, Church TS. The fitness, obesity, and health equation: Is physical activity the common denominator? JAMA. 2004; 292(10): 1232-4.

26. Krist J, Wieder K, Klotng N, Obergbach A, alisch S. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts.2013, 6(1): 57-69.

27. SalamehA.Graded exercise stress testing: Treadmill protocols comparison of peak exercise times in cardiac patients. Master Thesis. Ohio, US: University of Akron; 2009.

28. Pollock ML, Gaesser GA, Butcher JD, Dishman RK, Franklin BA, et al. ACSM position stand: The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. ACSM. 1998, 30(6): 975-91.

29. WeirJB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949; 109(1-2):1-9.

30. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.J Appl Physiol. 1974; 37(2):247-8.

31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28­(7): 412–9.

32. Trayhurn P, Wood I. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3):347-55.

33. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003; 42(5):861-8.

34. Zhu F, Weijie Li, Yanjie C, Wang Ch, Wang Y, Liang D, et al. Apelin stimulates glucose uptake through the P13K/AKt pathway and improves insulin resistance.Mol Cell Biochem. 2011; 353(1-2):305-13.

35. Dray C, Bost F, Castan L, Francois J, Laville M, Vidal H, et al. Apelin and AOJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab. 2010; 298(6):1161-9.

36. Weltman A, Weltman JY, Roy C, Wideman L, Patrie J, Johannes D, et al. Growth hormone response to graded exercise intensities is attenuated and the gender difference abolished in older adults. Journal of Applied Physiology. 2006, 100(5): 1623-9.

37. Højbjerre L, Rosenzweig M, Dela F, Bruun JM, Stallknecht B. Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects. Eur J Endocrinol. 2007; 157(5):613-23.

38. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005; 98(4):1154-62.

39. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, et al. TNFα up-regulates apelin expression in human and mouse adipose tissue. The FASEB Journal. 2006; 20(9): 1528-30.

40. Wright D, Sutherland L. Exercise increases apelin expression in white adipose tissue. Medicine & Science in Sports& Exercise. 2009; 41(5): 38.

41. شیبانی شهین، شمشکی افسانه، حناچی پریچهر. اثر تمرین رست بر میزان اپلین پلاسما و فشارخون در زنان دونده. نشریۀ علوم پزشکی قم. 1391؛ 6(3):31 ـ27.

42. گله­داری محمد، آذربایجانی محمد­علی. تأثیر نوع تمرین طی محدودیت کالری بر غلظت ادیپوکاین­های پلاسمای مردان چاق. نشریۀ فیزیولوژی ورزشی. ­1393؛ 6(24): 121 ـ38.

43. ابراهیمی محسن، رحمانی­نیا فرهاد، دمیرچی ارسلان، میرزایی بهمن. اثر شدت فعالیت هوازی بر انرژی دریافتی، اشتها و هورمون­های تنظیم­کنندۀ انرژی در مردان جوان غیر­فعال. نشریۀ فیزیولوژی ورزشی.­ 1393؛ 5(20): 28 ـ15.